Daiwa Securities Group Inc. - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$0
-100.0%
1150.0%0.00%
Q2 2021$1,0000.0%1150.0%0.00%
Q1 2021$1,0000.0%1150.0%0.00%
Q4 2020$1,0000.0%115
-57.2%
0.00%
Q3 2020$1,000
-50.0%
2690.0%0.00%
Q2 2020$2,0000.0%2690.0%0.00%
Q1 2020$2,0000.0%2690.0%0.00%
Q4 2019$2,0000.0%2690.0%0.00%
Q3 2019$2,000
-33.3%
2690.0%0.00%
Q2 2019$3,000
+50.0%
2690.0%0.00%
Q1 2019$2,000
-71.4%
269
-32.8%
0.00%
Q4 2018$7,0004000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders